F
Feng Zhang
Researcher at Fudan University
Publications - 2715
Citations - 225233
Feng Zhang is an academic researcher from Fudan University. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 172, co-authored 1278 publications receiving 181865 citations. Previous affiliations of Feng Zhang include Cincinnati Children's Hospital Medical Center & Nanjing Medical University.
Papers
More filters
Journal ArticleDOI
SOD1 gene transfer into paraventricular nucleus attenuates hypertension and sympathetic activity in spontaneously hypertensive rats
TL;DR: Results indicate that SOD1 overexpression in the PVN reduces arterial blood pressure, attenuates excessive sympathetic activity and CSAR, and improves myocardial and vascular remodeling in SHR.
Journal ArticleDOI
Meta-analysis of five randomized clinical trials comparing sirolimus- versus paclitaxel-eluting stents in patients with diabetes mellitus
Feng Zhang,Lili Dong,Junbo Ge +2 more
TL;DR: SES are superior to PES in reducing the incidences of restenosis and target lesion revascularization in patients with diabetes, with nonsignificant differences in terms of cardiac death, myocardial infarction, and stent thrombosis.
Journal ArticleDOI
Neural integration of reward, arousal, and feeding: recruitment of VTA, lateral hypothalamus, and ventral striatal neurons.
TL;DR: It is argued that selective spatiotemporal recruitment and coordinated spiking activity among these cell type‐specific neural circuits may underlie the neural integration of reward, learning, arousal and feeding.
Journal ArticleDOI
CRISPR/Cas9: Prospects and Challenges
TL;DR: Further advances of the CRISPR/Cas9 toolbox are helping researchers discover new gene functions with high sensitivity and precision, and this new technology, with its ease of customization and high efficiency, has made it possible to manipulate virtually any model organism of choice.
Patent
Systems, methods, and compositions for targeted nucleic acid editing
TL;DR: In this paper, the authors describe RNA-targeting systems, methods, and compositions for targeting and editing nucleic acids, including a Casl3 protein, at least one guide molecule, and at least an adenosine deaminase protein or catalytic domain thereof.